Management of the Immune Reconstitution Inflammatory Syndrome

被引:0
作者
Graeme Meintjes
James Scriven
Suzaan Marais
机构
[1] University of Cape Town,Clinical Infectious Diseases Research Initiative, Institute of Infectious Diseases and Molecular Medicine
[2] University of Cape Town,Division of Infectious Diseases and HIV Medicine
[3] GF Jooste Hospital,Department of Medicine
[4] Imperial College London,Liverpool School of Tropical Medicine
[5] Liverpool University,Division of Neurology, Department of Medicine
[6] University of Cape Town,Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences
[7] University of Cape Town,undefined
来源
Current HIV/AIDS Reports | 2012年 / 9卷
关键词
HIV; AIDS; Antiretroviral therapy; Immune reconstitution inflammatory syndrome; Tuberculosis; Cryptococcosis; Mycobacterial disease; Cytomegalovirus; Kaposi’s sarcoma; Progressive multifocal leukoencephalopathy; Viral hepatitis; Corticosteroids;
D O I
暂无
中图分类号
学科分类号
摘要
The immune reconstitution inflammatory syndrome (IRIS) is a frequent early complication of antiretroviral therapy (ART) in patients with advanced HIV. Because there is no confirmatory diagnostic test, the diagnosis is based on clinical presentation and exclusion of alternative causes for deterioration, such as antimicrobial drug resistance. Opportunistic infection treatment should be optimized. Mild cases may require symptomatic therapy alone or nonsteroidal anti-inflammatory drugs. Corticosteroids have been used to treat more severe cases of IRIS associated with mycobacterial and fungal infections. There is evidence from a randomized controlled trial that prednisone reduces morbidity and improves symptoms in paradoxical tuberculosis (TB)-IRIS. Neurological TB-IRIS is potentially life-threatening; high-dose corticosteroids are indicated and ART interruption should be considered if level of consciousness is depressed. When considering corticosteroid treatment clinicians should be aware of their side effects and only use them when the diagnosis of IRIS is certain. In viral forms of IRIS corticosteroids are generally avoided.
引用
收藏
页码:238 / 250
页数:12
相关论文
共 434 条
  • [31] Maartens G(2004)Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy Clin Infect Dis 39 1709-3
  • [32] Lawn SD(2007)Hepatic involvement with tuberculosis-associated immune reconstitution disease AIDS 21 2362-7
  • [33] Meintjes G(2011)A practical approach to the diagnosis and management of paradoxical tuberculosis immune reconstitution inflammatory syndrome Contin Med Educ 29 410-83
  • [34] Meintjes G(2011)Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)–associated tuberculous meningitis Clin Infect Dis 52 1374-6
  • [35] Wilkinson RJ(2010)Central nervous system disorders after starting antiretroviral therapy in South Africa AIDS 24 2871-45
  • [36] Morroni C(2008)Immune reconstitution disease of the central nervous system Curr Opin HIV AIDS 3 438-2
  • [37] Lehloenya R(2007)A new presentation of immune reconstitution inflammatory syndrome followed by a severe paradoxical reaction in an HIV-1-infected patient with tuberculous meningitis AIDS 21 381-32
  • [38] Meintjes G(2007)Immune reconstitution inflammatory syndrome associated with disseminated mycobacterial infection in patients with AIDS AIDS Patient Care STDS 21 527-9
  • [39] Meintjes G(2007)Immune reconstitution syndrome in a patient with AIDS with paradoxically deteriorating brain tuberculoma AIDS Patient Care STDS 21 234-63
  • [40] Rangaka MX(2006)Immune reconstitution inflammatory syndrome of tuberculosis among HIV-infected patients receiving antituberculous and antiretroviral therapy J Infect 53 357-43